Extended Data Fig. 1: Mean (SD) concentration-time profiles of ABBV-706 conjugate, total antibody, and free Top1i payload at ABBV-706 1.8 mg kg−1 Q3W in cycle 1 as monotherapy.
Q3W, every 3 weeks; SD, standard deviation; Top1i, topoisomerase 1 inhibitor.
